We observed that influenza immunopeptides were only presented for the secondary length preferences of patient allotypes HLA-A*03:01 and HLA-B*18:01: 10-mers and 8-mers respectively (Fig 3 and Table 1). The gene discussed is HLA-A; the disease is influenza.